Emilio Perucca

245 Burgundy Street
Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 237 publications

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.

Journal: Epilepsia

Published: May 07, 2026

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.

Journal: Epilepsia

Published: May 07, 2026

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain.

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain.

Journal: Epilepsia

Published: April 24, 2026

Outcomes of out-of-hospital treatment of impending tonic-clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis.

Outcomes of out-of-hospital treatment of impending tonic-clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis.

Journal: Epilepsia

Published: April 09, 2026

Novel pharmacological therapies in development.

Novel pharmacological therapies in development.

Journal: Current opinion in neurology

Published: February 02, 2026

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Journal: Neurology

Published: January 14, 2026

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.

Journal: Epilepsia

Published: December 19, 2025

Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

Journal: The Lancet. Neurology

Published: December 05, 2025

Novel epilepsy treatments in clinical development.

Novel epilepsy treatments in clinical development.

Journal: Epilepsy & behavior : E&B

Published: December 04, 2025

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Journal: Drugs

Published: November 26, 2025

Epilepsy, neuroinflammation and cannabidiol What do we know thus far?

Epilepsy, neuroinflammation and cannabidiol What do we know thus far?

Journal: Frontiers in pharmacology

Published: November 18, 2025

Drug-treatment changes, depression, and quality of life in adults with drug-resistant focal epilepsy.

Drug-treatment changes, depression, and quality of life in adults with drug-resistant focal epilepsy.

Journal: Epilepsia

Published: September 03, 2025

Showing 1-12 of 237

Last Updated: 09/26/2026